Insulin resistance has been widely recorded in malignant tumors contributing to cancer cachexia due to chronic exposure to pro-inflammatory cytokines, such as TNF-a, IL-6, and insulin growth factor binding protein [45]. This evidence concerns the gene IL6 and cancer.